4Expert Panel on detection,evaluation and treatment of high blood cholesterol in adults.Executive summary of the third report of the NCEP[J].JAMA,2009,285(19):2486-2497. 被引量：1
5Shal'nev VI.The effects of early application of simvastatin on C-re-active protein level blood lipids,and the clinical course of acute coronary syndrome[J].Kiln Med(Mosk),2007,85(11):46-50. 被引量：1
6Forst T,Wilhelm B,Pfutxner A,et al.Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a popul-ation at high cardiovascular risk[J].Diab Vasc Dis Res,2008,5(4):298-303. 被引量：1
7Wu YF,Liu LQ,Li X,et a1.For the USA-PRC Collaborative Study ofCardiovascular and Cardiopumonary Epidemiology Research Groupand the China Multicenter Collaborative Study of CardiovascularEpidemiology China MUCA Research Group.Estimation of ten-year risk of fatal and non-fatal ischemic cardiovascular diseases inChinese[J].Circulation,2009,114(21):2217-2225. 被引量：1
8Expert Panel on Detection,Evaluation and Treatment of High Blood Cholesterol in Adults.Executive Summary of The Third Report of The National Cholesterol Education Program(NCEP)Expert Panel on Detection,Evaluation,And Treatment of HighBlood Cholesterol In Adults(Adult Treatment Panel III)[J],JAMA,2001,285(19):2486-2497. 被引量：1
9Shal'nev VI.The effects of early application of simvastatin on C-reactive protein level blood lipids,and the clinical course of acute coronary syndrome[J].Kiln Med(Mosk),2007,85(11):46-50. 被引量：1
